Yellow Nail Syndrome (YNS) is a rare medical disorder that primarily affects the nails of the fingers and toes. It is characterized by yellow discoloration and thickening of the nails of the digits due to accumulation of endothelial cells, which results in abnormal hardening and increased curvature. The exact cause of YNS is unknown, but it is thought to be due to an underlying lymphatic disorder, such as lymphatic malformation or lymphocytic leukocytosis. It is believed that the excessive accumulation of endothelial cells in the nail bed leads to the typical yellowish discoloration of the nail plate. Patients with YNS typically experience pain and discomfort due to the abnormal thickening and curling of their nails. Additionally, those affected by the condition may experience peels and ridging of the nail from the presence of the hardening cells. In some cases, nails may become so thick they impede one’s ability to wear footwear normally. There is no universal treatment for YNS, but some common treatments focus on softening the nails and reducing their thickness. A dermatologist may recommend medications such as topical antifungal agents, intralesional triamcinolone, retinoids, and oral steroids. Additionally, light curettage of the nails and laser ablation can be used to remove the thickened cells. Although YNS is rare, people of any age or gender can be affected. If you or a family member is experiencing yellow discoloration and thickening of the nails, seeing a dermatologist for evaluation may be beneficial. Even though there is no known cure, there are treatments that can provide relief and improve nail aesthetics.
Title : Personalized and precision dermatology through the view of biodesign-inspired translational & data-driven applications: Revolutionary skin treatments for every concern in clinical dermatology integrating skin care experts and consumers
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Modern non-invasive methods for in vivo assessment of skin
Georgios N Stamatas, SGS, France
Title : Paraneoplastic autoimmune multiorgan syndrome or PAMS: Paraneoplastic pemphigus revisited
Sergei A Grando, University of California Irvine, United States
Title : The next generation of threads: Lifting, volumization, and biostimulation in one powerful triple action
George Sulamanidze, Plastic Surgeon at Clinic of Plastic and Aesthetic Surgery and Cosmetology TOTALCharm, Georgia
Title : Personalized and precision medicine as a unique avenue to have the healthcare model renewed to secure the national biosafety: Advanced skincare solutions in individualized cosmetology, reconstructive plastic surgery and the modern beauty
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Integrating personalized and precision medicine into dermatology clinical practice securing its potential to get skin diseases cured and to revolutionize dermatooncology
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antifungal resistance in dermatophytes: A growing concern
Jannatul Sharmin Joarder, Dhaka Medical College Hospital, Bangladesh
Title : An analysis of alopecia areata incognita following mRNA COVID-19 vaccination in perimenopausal women
Lynn Priscilla Fadel, California Health Sciences University, United States
Title : 1D Fractal signatures computer-aided diagnosis methodologies for skin lesion classification
Selene Solorza Calderon, Universidad Autonoma de Baja California, Mexico
Title : Café au lait spot is a marker for pheochromocytoma in hypertensive crisis with a wide-differential diagnosis: A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt